Pathology of bone tumours: Personal experience

Preamble to the study of cartilaginous tumours.- 1. Chondroma.- 2. Chondrosarcoma.- 3. Clear-cell chondrosarcoma.- 4. Mesenchymal chondrosarcoma.- 5. Chondroblastoma.- 6. Osteogenic exostosis (osteochondroma), multiple exostoses, subungual exostosis, metachondromatosis.- 7. Osteoid osteoma and osteoblastoma.- 8. Osteoid osteoma.- 9. Benign osteoblastoma.- 10. Osteoma.- 11. Osteogenic sarcoma.- 12. Cortico-metaphyseal fibrous defect, non-ossifying fibroma, multiple fibromas, benign fibrous histiocytoma.- 13. Xanthoma.- 14. Desmoid fibroma.- 15. Chondromyxoid fibroma.- 16. Malignant fibrous histiocytoma.- 17. Fibroblastic sarcoma.- 18. Ewing’s sarcoma, neuroepithelioma and Askin’s tumour.- 19. Adamantinoma of the long bones.- 20. Chordoma.- 21. Giant-cell tumour.- 22. Haemangioendothelioma.- 23. Haemangiopericytoma.- 24. Glomus tumour.- 25. Haemangioma.- 26. Lymphangioma.- 27. Lipoma, liposarcoma.- 28. Myxoma, fibromyxoma.- 29. Idiopathic cyst, juxta-articular and related cyst, epidermoid cyst, hydatid cyst.- 30. Aneurysmal cyst.- 31. Langerhans’cell histiocytosis: histiocytosis X, eosinophil granuloma.- 32. Fibrous dysplasia.- 33. Metastases (secondary cancers of bone).- 34. Malignant lymphoma.- 35. Hodgkin’s disease.- 36. Plasma-cell proliferations.- 37. Leiomyosarcoma, rhabdomyosarcoma.- 38. Craniofacial tumours and pseudotumours.- 39. Extraskeletal skeletogenic tumours.- 40. Bony and osteoperiosteal pseudotumours.- 41. Calcified and/or ossified lesions of the soft tissues and various disorders affecting bone.- Technical notes.

Contains over 1100 radiographic and histologic illustrations Dealing basically with malignant and benign bone tumors, it also includes extra-skeletal skeletogenic tumors and pseudo-tumoral lesions that may be confused with true tumors Each chapter is structured with clinical cases, discussion, illustrations and references An insert at the end of the chapter reminds of the chief differential diagnoses and the pitfalls to be avoided The text has profited from the author's collaboration with the reseach teams of the Institut Curie, one of the most wellknown French cancer research institutes